Patents by Inventor Hiroyuki Shirono

Hiroyuki Shirono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12138922
    Abstract: A liquid ejection device includes a head having a nozzle, an element causing the nozzle to eject liquid, a reservoir configured to store the liquid to be supplied to the nozzle, and a controller. The controller is configured to change a drive signal to drive the element based on a quantity of the liquid stored in the reservoir.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: November 12, 2024
    Assignee: BROTHER KOGYO KABUSHIKI KAISHA
    Inventors: Sosuke Kuroyanagi, Yoshinori Osakabe, Hiroyuki Ishikawa, Fumio Nakazawa, Taichi Shirono
  • Patent number: 8465733
    Abstract: Disclosed are a method for producing a frozen pharmaceutical composition prepared from cultured human mesenchymal stem cells and a pharmaceutical composition containing human mesenchymal stem cells. This method is a method for producing a frozen pharmaceutical composition containing human mesenchymal stem cells, which comprises the following steps in this order: (a) adding trypsin to human mesenchymal stem cells in a culture vessel to detach the cells from the surface of the culture vessel; (b) adding a bicarbonate Ringer's solution containing human serum albumin to the detached cells to terminate the reaction with trypsin, and washing the cells with the bicarbonate Ringer's solution containing human serum albumin; (c) suspending the cells in a bicarbonate Ringer's solution containing human serum albumin and dimethyl sulfoxide; (d) putting the resulting suspension in a container which allows freezing of what is contained therein, and sealing the container; and (e) freezing the suspension put in the container.
    Type: Grant
    Filed: October 27, 2008
    Date of Patent: June 18, 2013
    Assignee: JCR Pharmaceuticals Co., Ltd.
    Inventors: Hiroyuki Shirono, Youngjin Byun, Shoichiro Kamei, Kiwamu Imagawa
  • Publication number: 20110274663
    Abstract: Disclosed are a method for producing a frozen pharmaceutical composition prepared from cultured human mesenchymal stem cells and a pharmaceutical composition containing human mesenchymal stem cells. This method is a method for producing a frozen pharmaceutical composition containing human mesenchymal stem cells, which comprises the following steps in this order: (a) adding trypsin to human mesenchymal stem cells in a culture vessel to detach the cells from the surface of the culture vessel; (b) adding a bicarbonate Ringer's solution containing human serum albumin to the detached cells to terminate the reaction with trypsin, and washing the cells with the bicarbonate Ringer's solution containing human serum albumin; (c) suspending the cells in a bicarbonate Ringer's solution containing human serum albumin and dimethyl sulfoxide; (d) putting the resulting suspension in a container which allows freezing of what is contained therein, and sealing the container; and (e) freezing the suspension put in the container.
    Type: Application
    Filed: October 27, 2008
    Publication date: November 10, 2011
    Applicant: JCR Pharmaceuticals Co., Ltd.
    Inventors: Hiroyuki Shirono, Youngjin Byun, Shoichiro Kamei, Kiwamu Imagawa
  • Publication number: 20110262402
    Abstract: Provided is a pharmaceutical composition and a method for the treatment and/or prophylaxis of arthritis, inter alia, rheumatoid arthritis. The pharmaceutical composition comprises human mesenchymal stem cells, and the method comprises administering an effective amount human mesenchymal stem cells to a patient.
    Type: Application
    Filed: September 4, 2008
    Publication date: October 27, 2011
    Inventors: Masahiko Kuroda, Masakatsu Takanashi, Katsuko Sudo, Shigeki Yamauchi, Hiroyuki Shirono, Toru Hirado, Kenichi Maeda
  • Publication number: 20030044909
    Abstract: The present invention provides materials capable of screening human melatonin which comprise an animal cell containing an expression plasmid for the gene encoding a human melatonin receptor protein and having said protein expressed therein, as well as a method for screening the same, thus permitting not only human melatonin but also hormones showing affinity for the same, and their agonists or antagonists to be screened with an enhanced degree of precision.
    Type: Application
    Filed: March 29, 2002
    Publication date: March 6, 2003
    Applicant: JCR PHARMACEUTICALS Co., Ltd.
    Inventors: Tetsuo Yokoyama, Hiroyuki Shirono, Jun-Ichi Koga
  • Patent number: 5240864
    Abstract: Antiserum which can recognize all subtypes of human leukocyte interferon is prepared from the blood of an animal immunized with partially purified human leukocyte interferon obtained from a culture of human leukocyte stimulated with Sendai virus.The antiserum is added to a column whereon concentrated culture broth of human leukocyte has been immobilized to adsorb impurities, the effluent is added to a column whereon partially purified human leukocyte interferon has been immobilized to adsorb anti-human leukocyte interferon antibody and then the antibody is eluted from the column.The antibody thus obtained recognizes all subtypes of human leukocyte interferon and can be separated by a chromatography to each monoclonal antibody which recognizes a single subtype.Employing these antibodies, the subtypes of human leukocyte interferon or their antibodies in a sample can be analized or assayed.
    Type: Grant
    Filed: December 4, 1990
    Date of Patent: August 31, 1993
    Assignee: JCR Pharmaceuticals Co., Ltd.
    Inventors: Junichi Koga, Hiroyuki Shirono, Akio Matsuo, Hajime Hiratani